logo 03 logo 05 logo 07

Press release

 

AstraZeneca to collaborate with Inserm in type 2 diabetes and chronic kidney disease studies

Learn More


Press release

Creation of HalioDx: A management buy-out by the QIAGEN Marseille Executive team to become the reference diagnostic company in immuno-oncology

 Learn More

 




INSERM TRANSFERT
Paris Biopark - 7 rue Watt - 75013 PARIS
Phone  +33 (0)1 55 03 01 00
Fax +33 (0)1 55 03 01 60
contact@inserm-transfert.fr